Euro-Med Laboratories Philippines (PHS:EURO) LT-Debt-to-Total-Asset: 0.08 (As of Mar. 2026)


PHS:EURO Euro-Med Laboratories Philippines Inc PHS:EURO
85 GF Score
Price ₱1.06
GF Value ₱1.03
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Euro-Med Laboratories Philippines LT-Debt-to-Total-Asset?

Euro-Med Laboratories Philippines PHS:EURO -3.64% 85 LT-Debt-to-Total-Asset is 0.08 as of Mar. 2026. GuruFocus rates PHS:EURO with a GF Score™ of 85/100 and a GF Value™ of ₱1.03 (Fairly Valued). The stock has 7 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Euro-Med Laboratories Philippines's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.08.

Euro-Med Laboratories Philippines's long-term debt to total assets ratio increased from Mar. 2025 (0.08) to Mar. 2026 (0.08). It may suggest that Euro-Med Laboratories Philippines is progressively becoming more dependent on debt to grow their business.

Euro-Med Laboratories Philippines  (PHS:EURO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Euro-Med Laboratories Philippines LT-Debt-to-Total-Asset Related Terms

Euro-Med Laboratories Philippines LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Euro-Med Laboratories Philippines's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euro-Med Laboratories Philippines LT-Debt-to-Total-Asset Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.08 0.07 0.08 0.09

Euro-Med Laboratories Philippines Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.08 0.09 0.08
PHS:EURO
85GF Score
Euro-Med Laboratories Philippines Inc PHS:EURO
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euro-Med Laboratories Philippines LT-Debt-to-Total-Asset Calculation

Euro-Med Laboratories Philippines's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=962.68/11144.61
=0.09

Euro-Med Laboratories Philippines's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=920.52/11110.34
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.08 mean?
Euro-Med Laboratories Philippines (PHS:EURO) has a LT-Debt-to-Total-Asset of 0.08 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Euro-Med Laboratories Philippines and its competitors.
Is Euro-Med Laboratories Philippines' LT-Debt-to-Total-Asset too high?
Euro-Med Laboratories Philippines' current LT-Debt-to-Total-Asset is 0.08. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' LT-Debt-to-Total-Asset compare to ZTS and UTHR?
Euro-Med Laboratories Philippines' LT-Debt-to-Total-Asset of 0.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Euro-Med Laboratories Philippines and its competitors. Euro-Med Laboratories Philippines's current LT-Debt-to-Total-Asset is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.03, compared to a current price of ₱1.06 — trading 2.9% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.08. Euro-Med Laboratories Philippines' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current LT-Debt-to-Total-Asset is 0.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?

Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued. The current stock price of ₱1.06 is trading 2.9% above its estimated GF Value™ of ₱1.03. GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.

Key valuation signals for PHS:EURO:

  • LT-Debt-to-Total-Asset: 0.08
  • GF Value™: ₱1.03 vs. price of ₱1.06 (2.9% above fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euro-Med Laboratories Philippines Business Description

Address San Marcelino Street, United Nations Avenue corner, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
85GF Score

Get the complete analysis for PHS:EURO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱1.06
Price
₱1.03
GF Value